ARK Investment Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-771,172
| Closed | -$57.7M | – | 302 |
|
|
2021
Q1 | $57.7M | Sell |
771,172
-132,960
| -15% | -$9.95M | 0.11% | 123 |
|
|
2020
Q4 | $98.1M | Sell |
904,132
-217,119
| -19% | -$23.6M | 0.26% | 72 |
|
|
2020
Q3 | $99.1M | Buy |
1,121,251
+269,938
| +32% | +$23.9M | 0.59% | 44 |
|
|
2020
Q2 | $90.8M | Buy |
851,313
+261,373
| +44% | +$27.9M | 0.98% | 28 |
|
|
2020
Q1 | $35M | Buy |
589,940
+82,159
| +16% | +$4.87M | 0.87% | 29 |
|
|
2019
Q4 | $35.1M | Buy |
507,781
+124,308
| +32% | +$8.59M | 0.89% | 33 |
|
|
2019
Q3 | $39.8M | Buy |
383,473
+4,297
| +1% | +$446K | 0.87% | 33 |
|
|
2019
Q2 | $35.1M | Buy |
379,176
+79,906
| +27% | +$7.4M | 0.88% | 30 |
|
|
2019
Q1 | $27.4M | Buy |
299,270
+53,208
| +22% | +$4.86M | 0.78% | 32 |
|
|
2018
Q4 | $13.7M | Buy |
246,062
+23,875
| +11% | +$1.33M | 0.56% | 35 |
|
|
2018
Q3 | $26.5M | Buy |
222,187
+42,232
| +23% | +$5.03M | 0.8% | 38 |
|
|
2018
Q2 | $18.4M | Buy |
179,955
+29,466
| +20% | +$3.01M | 0.67% | 41 |
|
|
2018
Q1 | $19.5M | Buy |
150,489
+67,013
| +80% | +$8.7M | 0.97% | 34 |
|
|
2017
Q4 | $8.12M | Buy |
83,476
+70,006
| +520% | +$6.81M | 0.65% | 48 |
|
|
2017
Q3 | $1.98M | Buy |
13,470
+11,699
| +661% | +$1.72M | 0.24% | 64 |
|
|
2017
Q2 | $285K | Buy |
1,771
+946
| +115% | +$152K | 0.06% | 93 |
|
|
2017
Q1 | $131K | Buy |
825
+478
| +138% | +$75.9K | 0.04% | 89 |
|
|
2016
Q4 | $42K | Buy |
+347
| New | +$42K | 0.02% | 94 |
|